AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18553042 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium citrate (500 mg)
Number of subjects: 25
Study 18553042 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate (1,000 mg)
Number of subjects: 25
Study 15864622 — intervention group
Group type: EXPERIMENTAL
Intervention: Opposite clear corneal incisions (OCCIs)
Number of subjects: 57
Study 15864622 — intervention group
Group type: COMPARATOR
Intervention: Control group (no OCCI)
Number of subjects: 57
Study 12847386 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (200 mg in isotonic saline)
Number of subjects: 71
Study 12847386 — intervention group
Group type: COMPARATOR
Intervention: Placebo (isotonic saline)
Number of subjects: 71
Study 16021874 — intervention group
Group type: EXPERIMENTAL
Intervention: stavudine/didanosine
Number of subjects: 151
Study 16021874 — intervention group
Group type: COMPARATOR
Intervention: zidovudine/lamivudine
Number of subjects: 151
Study 16021874 — intervention group
Group type: COMPARATOR
Intervention: alternating treatment (stavudine/didanosine for 12 weeks followed by zidovudine/lamivudine)
Number of subjects: 151
Study 9051773 — intervention group
Group type: COMPARATOR
Intervention: Obstacle negotiation during locomotion
Number of subjects: 1
Study 9051773 — intervention group
Group type: COMPARATOR
Intervention: Verbal estimates of obstacle height
Number of subjects: 1
Study 9051773 — intervention group
Group type: COMPARATOR
Intervention: Toe elevation estimation by raising one leg
Number of subjects: 1
Study 2064702 — intervention group
Group type: EXPERIMENTAL
Intervention: Taprosten (25 ng/kg bodyweight/minute intravenously)
Number of subjects: 22
Study 2064702 — intervention group
Group type: COMPARATOR
Intervention: Placebo (30 ml saline solution NaCl 0.9%)
Number of subjects: 22
Study 2064702 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Taprosten and placebo)
Number of subjects: 22
Study 6626917 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical resection
Number of subjects: 180
Study 6626917 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical by-pass
Number of subjects: 180
Study 6626917 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous prosthesis
Number of subjects: 180
Study 6626917 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic prosthesis
Number of subjects: 180
Study 6626917 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy (for papillary tumours)
Number of subjects: 180
Study 30536120 — intervention group
Group type: EXPERIMENTAL
Intervention: Panicum maximum supplemented with Lablab purpureus pellets
Number of subjects: 20
Study 30536120 — intervention group
Group type: EXPERIMENTAL
Intervention: Panicum maximum supplemented with Calopogonium mucunoides pellets
Number of subjects: 20
Study 30536120 — intervention group
Group type: EXPERIMENTAL
Intervention: Panicum maximum supplemented with Mucuna pruriens pellets
Number of subjects: 20
Study 30536120 — intervention group
Group type: COMPARATOR
Intervention: Sole Panicum maximum (control)
Number of subjects: 20
Study 30311848 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse Family Partnership plus IPV prevention intervention (NFP+)
Number of subjects: 238
Study 30311848 — intervention group
Group type: COMPARATOR
Intervention: Nurse Family Partnership only (Control)
Number of subjects: 238
Study 26711163 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized multisession telephone counseling protocol (n=270)
Number of subjects: 577
Study 26711163 — intervention group
Group type: COMPARATOR
Intervention: Transfer to state quit-line for counseling (n=307)
Number of subjects: 577
Study 25192793 — intervention group
Group type: EXPERIMENTAL
Intervention: Active group (12-week Aboriginal and Torres Strait Islander Women's Fitness Program)
Number of subjects: 49
Study 25192793 — intervention group
Group type: COMPARATOR
Intervention: Waitlisted group (12-month wait for the program)
Number of subjects: 49
Study 22853988 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (dietary and cooking classes with mindfulness training)
Number of subjects: 36
Study 22853988 — intervention group
Group type: COMPARATOR
Intervention: Control group (wait-list control)
Number of subjects: 36
Study 20558907 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonazoid (ultrasound contrast agent)
Number of subjects: 85
Study 20558907 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 85
Study 17665488 — intervention group
Group type: EXPERIMENTAL
Intervention: class exercise
Number of subjects: 220
Study 17665488 — intervention group
Group type: EXPERIMENTAL
Intervention: home exercise using a videotape
Number of subjects: 220
Study 17665488 — intervention group
Group type: COMPARATOR
Intervention: control group
Number of subjects: 220
Study 16118028 — intervention group
Group type: EXPERIMENTAL
Intervention: 11PCV with aluminum adjuvant
Number of subjects: 0
Study 16118028 — intervention group
Group type: COMPARATOR
Intervention: 11PCV without aluminum adjuvant
Number of subjects: 0
Study 12838194 — intervention group
Group type: COMPARATOR
Intervention: Standard regimen (5000 IU 3 times per week for 4 weeks)
Number of subjects: 120
Study 12838194 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose regimen (10,000 IU 3 times per week)
Number of subjects: 120
Study 12838194 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-per-week regimen (15,000 IU once per week)
Number of subjects: 120
Study 10418864 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous crossed‐pin fixation followed by plaster of Paris cast immobilization
Number of subjects: 50
Study 10418864 — intervention group
Group type: COMPARATOR
Intervention: Conventional plaster of Paris cast immobilization
Number of subjects: 50
Study 7743787 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped-care regimen (initial treatment with niacin followed by other agents if needed)
Number of subjects: 612
Study 7743787 — intervention group
Group type: COMPARATOR
Intervention: Lovastatin (HMG-CoA reductase inhibitor)
Number of subjects: 612
Study 2289390 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (100 mg rectal suppository one hour pre-operatively)
Number of subjects: 100
Study 2289390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 31301106 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-aging biocellulose masks
Number of subjects: 69
Study 31301106 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifting biocellulose masks
Number of subjects: 69
Study 31301106 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell renewal biocellulose masks
Number of subjects: 69
Study 31357685 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Low-Calorie Ketogenic Diet (VLCKD)
Number of subjects: 35
Study 31357685 — intervention group
Group type: COMPARATOR
Intervention: Very Low-Calorie Non-Ketogenic Diet (VLCnKD)
Number of subjects: 35
Study 28673219 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,200 ml carbohydrate solution leading up to admission (up until two hours pre-colonoscopy)
Number of subjects: 398
Study 28673219 — intervention group
Group type: COMPARATOR
Intervention: Routine fasting (minimum seven hours)
Number of subjects: 398
Study 26173719 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose CT (LDCT) screening
Number of subjects: 4061
Study 26173719 — intervention group
Group type: COMPARATOR
Intervention: Non-participation questionnaire (NPQ)
Number of subjects: 4061
Study 23889863 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-coil ICD leads
Number of subjects: 0
Study 23889863 — intervention group
Group type: COMPARATOR
Intervention: Single-coil ICD leads
Number of subjects: 0
Study 21477333 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Saliva natura (SN)
Number of subjects: 14
Study 21477333 — intervention group
Group type: COMPARATOR
Intervention: Glandosane (G)
Number of subjects: 14
Study 21477333 — intervention group
Group type: EXPERIMENTAL
Intervention: Both saliva substitutes (SN and G)
Number of subjects: 14
Study 19380444 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA Working Group definition of PSA progression
Number of subjects: 1675
Study 19380444 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate Cancer Working Group (PCWG 2008) definition of PSA progression
Number of subjects: 1675
Study 19380444 — intervention group
Group type: COMPARATOR
Intervention: PCWG 2008 definition of PSA-P
Number of subjects: 1675
Study 16951526 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligustrazine (LI) group
Number of subjects: 71
Study 16951526 — intervention group
Group type: COMPARATOR
Intervention: Sodium hyaluronate (SH) group
Number of subjects: 71
Study 16951526 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 71
Study 15599323 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab 1 mg/kg on day 0 and every 14 days for five doses (group 1, n = 30)
Number of subjects: 52
Study 15599323 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab 2 mg/kg on day 0 and on the day of discharge (group 2, n = 22)
Number of subjects: 52
Study 15599323 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab 1 mg/kg (group 1)
Number of subjects: 52
Study 15599323 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab 2 mg/kg (group 2)
Number of subjects: 52
Study 11155812 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 5 mg daily
Number of subjects: 196
Study 11155812 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study 9165608 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (2 micrograms, intravenously)
Number of subjects: 0
Study 9165608 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (200 micrograms, orally)
Number of subjects: 0
Study 9165608 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin treatment (both intravenous and oral)
Number of subjects: 0
Study 8166777 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg)
Number of subjects: 52
Study 8166777 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 2871285 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (Az)
Number of subjects: 21
Study 2871285 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 29363373 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course low-dose oral prednisolone (tapering doses over 2 weeks)
Number of subjects: 0
Study 29363373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29363373 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course low-dose oral prednisolone
Number of subjects: 0
Study 28481068 — intervention group
Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (EPN) in group A
Number of subjects: 44
Study 28481068 — intervention group
Group type: COMPARATOR
Intervention: Standard fluid therapy in group B
Number of subjects: 44
Study 25633257 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency thermotherapy (RF)
Number of subjects: 13
Study 25633257 — intervention group
Group type: COMPARATOR
Intervention: Bone-anchored suspension technique (BAST)
Number of subjects: 13
Study 24231012 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine-supplemented group (GlnPN)
Number of subjects: 30
Study 24231012 — intervention group
Group type: COMPARATOR
Intervention: Control group (Standard PN)
Number of subjects: 30
Study 21811136 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobicistat 150 mg with atazanavir and emtricitabine/tenofovir df
Number of subjects: 0
Study 21811136 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir 100 mg with atazanavir and emtricitabine/tenofovir df
Number of subjects: 0
Study 19726078 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (600 mg loading dose) with PPI
Number of subjects: 13809
Study 19726078 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (600 mg loading dose) without PPI
Number of subjects: 13809
Study 19726078 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel (60 mg loading dose) with PPI
Number of subjects: 13809
Study 19726078 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel (60 mg loading dose) without PPI
Number of subjects: 13809
Study 19726078 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 13809
Study 19726078 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 13809
Study 16807438 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus cisplatin (GC)
Number of subjects: 405
Study 16807438 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate/vinblastine/doxorubicin/cisplatin (MVAC)
Number of subjects: 405
Study 15296999 — intervention group
Group type: EXPERIMENTAL
Intervention: Driving simulator performance in narcolepsy patients
Number of subjects: 23
Study 15296999 — intervention group
Group type: COMPARATOR
Intervention: Driving simulator performance in healthy controls
Number of subjects: 23
Study 15296999 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological testing in narcolepsy patients
Number of subjects: 23
Study 15296999 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up investigation after optimising therapy in narcolepsy patients
Number of subjects: 23
Study 15296999 — intervention group
Group type: EXPERIMENTAL
Intervention: Driving simulator performance
Number of subjects: 23
Study 11255137 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0-g glycerol x kg body weight(-1) + 30% of the total rehydration water volume (GLY)
Number of subjects: 8
Study 11255137 — intervention group
Group type: COMPARATOR
Intervention: 30% of the total rehydration water volume without glycerol (CON)
Number of subjects: 8
Study 9249117 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural meperidine 25 mg diluted with saline to 2 mL (12.5 mg/mL)
Number of subjects: 36
Study 9249117 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural meperidine 25 mg diluted with saline to 5 mL (5 mg/mL)
Number of subjects: 36
Study 9249117 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural meperidine 25 mg diluted with saline to 10 mL (2.5 mg/mL)
Number of subjects: 36
Study 8074624 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin 200 mg
Number of subjects: 35
Study 8074624 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 2491981 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG) IUD
Number of subjects: 1905
Study 2491981 — intervention group
Group type: COMPARATOR
Intervention: Copper T 380Ag
Number of subjects: 1905
Study 2491981 — intervention group
Group type: COMPARATOR
Intervention: Copper T 220C
Number of subjects: 1905
Study 2491981 — intervention group
Group type: COMPARATOR
Intervention: Copper T 200B
Number of subjects: 1905
Study 2491981 — intervention group
Group type: COMPARATOR
Intervention: Copper devices (all types)
Number of subjects: 1905
Study 2491981 — intervention group
Group type: COMPARATOR
Intervention: All devices
Number of subjects: 1905
Study 979562 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (vowel-cancelling task on day 2)
Number of subjects: 36
Study 979562 — intervention group
Group type: COMPARATOR
Intervention: Control group (heavy interpolated fatigue on the first 3 days)
Number of subjects: 36
Study 31790543 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine, 0.4 mg/kg/d (maximum, 17 mg/d)
Number of subjects: 87
Study 31790543 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 31790543 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 87
Study 31184938 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.8% THC
Number of subjects: 118
Study 31184938 — intervention group
Group type: COMPARATOR
Intervention: 0% THC (placebo)
Number of subjects: 118
Study 29246130 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral water-soluble vitamin A (5000 IU once a day)
Number of subjects: 188
Study 29246130 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study 27311165 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser assisted hatching (quarter technique)
Number of subjects: 303
Study 27311165 — intervention group
Group type: COMPARATOR
Intervention: Control group (no assisted reproductive techniques)
Number of subjects: 303
Study 24942766 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan/Amlodipine 10/5 mg
Number of subjects: 0
Study 24942766 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan/Amlodipine 20/5 mg
Number of subjects: 0
Study 24942766 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan/Amlodipine 40/5 mg
Number of subjects: 0
Study 24942766 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan/Amlodipine 40/10 mg
Number of subjects: 0
Study 24942766 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 0
Study 21883204 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 weeks of joint attention (JA) intervention
Number of subjects: 61
Study 21883204 — intervention group
Group type: COMPARATOR
Intervention: Preschool programs only (control)
Number of subjects: 61
Study 20022616 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 microg Cr supplementation
Number of subjects: 0
Study 20022616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18294111 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily abacavir 600 mg-lamivudine 300 mg
Number of subjects: 680
Study 18294111 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily abacavir 300 mg and lamivudine 150 mg
Number of subjects: 680
Study 15738823 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile-bearing total knee arthroplasty
Number of subjects: 0
Study 15738823 — intervention group
Group type: COMPARATOR
Intervention: Fixed-bearing total knee arthroplasty
Number of subjects: 0
Study 15307433 — intervention group
Group type: COMPARATOR
Intervention: Sulfadoxine-pyrimethamine (SP) alone (1.25 mg/kg based on pyrimethamine)
Number of subjects: 600
Study 15307433 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate plus SP (1 dose: 4 mg/kg/d for 1 day)
Number of subjects: 600
Study 15307433 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate plus SP (3 doses: 4 mg/kg/d for 3 days)
Number of subjects: 600
Study 10884466 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Doppler ultrasound with Valsalva maneuver (VM) for 5 seconds starting 5 seconds after the beginning of contrast injection
Number of subjects: 58
Study 10884466 — intervention group
Group type: COMPARATOR
Intervention: Transcranial Doppler ultrasound with no Valsalva maneuver
Number of subjects: 58
Study 10884466 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Doppler ultrasound with VM for 5 seconds starting 2 seconds after the beginning of contrast injection
Number of subjects: 58
Study 10884466 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Doppler ultrasound with VM for 5 seconds starting 8 seconds after the beginning of contrast injection
Number of subjects: 58
Study 10884466 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Doppler ultrasound with repetitive short VMs in between 2 and 13 seconds after the beginning of contrast injection
Number of subjects: 58
Study 9295836 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine (Group 1)
Number of subjects: 37
Study 9295836 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (Group 2)
Number of subjects: 37
Study 9295836 — intervention group
Group type: COMPARATOR
Intervention: Povidone-iodine (Group 3)
Number of subjects: 37
Study 9295836 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine (Group 1) and Chlorhexidine (Group 2)
Number of subjects: 37
Study 9295836 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 37
Study 8314410 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide group
Number of subjects: 130
Study 8314410 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 130
Study 3549705 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenelzine 75 mg
Number of subjects: 27
Study 3549705 — intervention group
Group type: COMPARATOR
Intervention: Imipramine 150 mg
Number of subjects: 27
Study 31728715 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent 5 doses of filgrastim (5 mcg/kg/day)
Number of subjects: 22
Study 31728715 — intervention group
Group type: COMPARATOR
Intervention: Once-a-cycle pegfilgrastim (6 mg)
Number of subjects: 22
Study 29625012 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexibility, toning, and balance DVD (FlexToBa™, FTB)
Number of subjects: 307
Study 29625012 — intervention group
Group type: COMPARATOR
Intervention: Healthy aging DVD control
Number of subjects: 307
Study 27297848 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet rich in virgin olive oil
Number of subjects: 1002
Study 27297848 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 1002
Study 24964913 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam auto-injector (AI)
Number of subjects: 129
Study 22741253 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group (electroacupuncture + Dalitong granule)
Number of subjects: 500
Study 22741253 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture group
Number of subjects: 500
Study 22741253 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalitong granule group
Number of subjects: 500
Study 22741253 — intervention group
Group type: EXPERIMENTAL
Intervention: Western medication group
Number of subjects: 500
Study 20088994 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Wii (VRWii)
Number of subjects: 20
Study 20088994 — intervention group
Group type: COMPARATOR
Intervention: Recreational Therapy (RT)
Number of subjects: 20
Study 18450594 — intervention group
Group type: EXPERIMENTAL
Intervention: Interocular disparity measurement using semicircular test and reference stimuli
Number of subjects: 55
Study 18450594 — intervention group
Group type: COMPARATOR
Intervention: Reference group of 11 healthy subjects
Number of subjects: 55
Study 15662532 — intervention group
Group type: EXPERIMENTAL
Intervention: Storage in water for 1 week
Number of subjects: 0
Study 15662532 — intervention group
Group type: EXPERIMENTAL
Intervention: Storage in lactic acid solution for 3 days
Number of subjects: 0
Study 15662532 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentin-restoration resin interfaces
Number of subjects: 0
Study 12869081 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 750 mg of intravenous cefuroxime
Number of subjects: 141